跳至主要内容
临床试验/NCT02605681
NCT02605681已完成不适用

Plasma Midkine Associated Organ Dysfunction and Vascular Injury in Sepsis

Southeast University, China1 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2016年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
26
试验地点
1
主要终点
28-day mortality

研究概览

简要总结

Plasma midkine has reported to be elevated in infection and a regulator of angiotensin-converting enzyme (ACE). We aimed to investigate the plasma midkine in septic patients and its association with 28-day mortality and organ function, and also with plasma ACE and angiotensin II.

详细描述

This study showed that Ang II induced endothelial injury in sepsis patients. Midkine has been shown to regulate the renin-angiotensin system and acts in the upstream signaling pathway of angiotensin (ANG) II. The investigators want to access the relationship between midkine level and ACE-Ang II induced endothelial injury in sepsis

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

28-day mortality

时间窗: up to 28 days

All the patients were followed-up to 28 days and all-cause mortality was recorded.

次要结局

未报告次要终点

研究者

发起方
Southeast University, China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jingyuan,Xu

Nanjing Zhongda hospital,Southeast University, China

Southeast University, China

研究点 (1)

Loading locations...

相似试验